Effect of Octreotide on experimental corneal neovascularization

Citation
T. Demir et al., Effect of Octreotide on experimental corneal neovascularization, ACT OPHTH S, 77(4), 1999, pp. 386-390
Citations number
35
Categorie Soggetti
Optalmology
Journal title
ACTA OPHTHALMOLOGICA SCANDINAVICA
ISSN journal
13953907 → ACNP
Volume
77
Issue
4
Year of publication
1999
Pages
386 - 390
Database
ISI
SICI code
1395-3907(199908)77:4<386:EOOOEC>2.0.ZU;2-S
Abstract
Purpose:To examine the ability of subcutaneously administered Octreotide ( a long acting somatostatin analogue) to serve as an inhibitory agent for co rneal neovascularization in eyes of Wistar Albino rats. Methods: Neovascular growth into the corneas of all the animals was induced by silver nitrate cauterization. Half of the animals which were randomly s elected for the Octreotide group received 30 micrograms systemic Octreotide for 7 days. The treatment was initiated on the same day as chemical cauter ization. The rest of the animals (control group) received no treatment. Sli t lamp and histopathologic examination of the corneas of both groups were p erformed at the end of the study period. Results: It was observed that the corneal neovascularization and histopatol ogic scores of the Octreotide group were significantly lower than those of the control group (p<0.001, p<0.01). Conclusion: Systemic administration of Octreotide inhibits the corneal neov ascular response in a rat model.